Does UPADACITINIB Cause Dermatitis atopic? 525 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 525 reports of Dermatitis atopic have been filed in association with UPADACITINIB (Rinvoq). This represents 0.8% of all adverse event reports for UPADACITINIB.
525
Reports of Dermatitis atopic with UPADACITINIB
0.8%
of all UPADACITINIB reports
1
Deaths
113
Hospitalizations
How Dangerous Is Dermatitis atopic From UPADACITINIB?
Of the 525 reports, 1 (0.2%) resulted in death, 113 (21.5%) required hospitalization, and 4 (0.8%) were considered life-threatening.
Is Dermatitis atopic Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 525 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Dermatitis atopic?
DUPILUMAB (33,670)
TRALOKINUMAB-LDRM (613)
RUXOLITINIB (211)
TACROLIMUS (200)
CRISABOROLE (134)
NEMOLIZUMAB-ILTO (117)
OMALIZUMAB (111)
ABROCITINIB (110)
PREDNISONE (105)
ADALIMUMAB (103)
Which UPADACITINIB Alternatives Have Lower Dermatitis atopic Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL